Bio Medica Laboratories IPO Details

SME NSE

Bio Medica Laboratories IPO Summary

Bio Medica Laboratories IPO DRHP (Draft Red Herring Prospectus) has been Filed with Exchange.

Bio Medica Laboratories IPO total issue size comprises 37,71,600 shares . This includes a fresh issue of 32,05,200 shares . Offer for Sale consists of 3,76,800 shares . Pre-issue shareholding stands at 91,80,001, which will increase to 1,25,74,801 post-issue.

Bio Medica Laboratories IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.

The Lead Managers for Bio Medica Laboratories IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Narnolia Financial Services Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Bio Medica Laboratories Limited DRHP.

Bio Medica Laboratories IPO Details

Open Date

Close Date

Listing Date

Issue Price

₹0 - ₹0

Face Value

₹10 per share

Lot Size

0 Shares

GMP

₹0

Issue Type

IPO

Listing On

NSE

Type

Book Built Issue

Pre-issue Shareholding

91,80,001 shares

Post-issue Shareholding

1,25,74,801 shares

Total Issue Size

37,71,600 shares

Fresh Issue

32,05,200 shares

Offer for Sale

3,76,800 shares

DRHP Status

Filed with Exchange

Bio Medica Laboratories IPO Lot Size

Application	Lots	Shares	Amount
To be announced

Bio Medica Laboratories IPO Reservation

Promoter Holding

Pre Issue:

99.99%

Post Issue:

Promoter Names:

Mr. Mukesh Mehta, Mr. Pradeep Mehta

Documents

DRHP

Bio Medica Laboratories IPO DRHP

Bio Medica Laboratories IPO Valuations

ROE99.59%

ROCE48.20%

DEBT/EQUITY1.02

RONW99.59%

PAT MARGIN25.64%

Bio Medica Laboratories Financial Information

Period Ended	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	39.12	19.53	17.57
Total Income	38.33	15.34	16.25
Profit After Tax	9.79	2.50	0.33
EBITDA	15.21	5.63	1.70
Net Worth	14.73	4.94	2.44
Reserves and Surplus	5.55	4.84	2.34
Total Borrowing	15.01	10.49	9.61
Amount in ₹ Crore

About Bio Medica Laboratories IPO

Bio Medica Laboratories specializes in the manufacturing of pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in the form of liquid iand dry powder injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.

Product portfolio:

Liquid Injectables: 58 products are offered under this category
Dry powder injectables: 15 products under this category

It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.

The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.

It has two manufacturing facilities in Indore, Madhya Pradesh.

Competitive Strengths

Multi-product capability and diversified product portfolio
Experienced promoters, management and employees.
Quality assurance
Established client relationship

Strength Of Bio Medica Laboratories IPO

To be announced

Risk Of Bio Medica Laboratories IPO

To be announced

Objectives Bio Medica Laboratories IPO

1. Repayment of Loan

2. Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises

3. General Corporate Purposes

Company Contact Details

Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: companysecretary@biomedica.co.in
Website: http://www.biomedica.co.in/

Registrar Contact Details

Name:

Skyline Financial Services Pvt Ltd

Phone:

+91-22-28511022

Email:

ipo@skylinerta.com

Website:

https://www.skylinerta.com/ipo.php

Lead Mangers

Market Maker

To be announced

Bio Medica Laboratories FAQs

The Bio Medica Laboratories IPO is a SME public issue comprising 3771600 equity shares with a face value of ₹10 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.

The IPO opens for subscription on TBA, and closes on TBA.

Skyline Financial Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE

The Bio Medica Laboratories IPO opens on TBA.

Bio Medica Laboratories IPO lot size is 0, and the minimum amount required for application is ₹0.

You may apply for the Bio Medica Laboratories IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Bio Medica Laboratories IPO is scheduled to be finalized on TBA. Subsequently, the shares allotted will be credited to investors’ demat accounts by TBA. Investors are advised to regularly check the Bio Medica Laboratories IPO allotment status for updates.

The listing date for the Bio Medica Laboratories IPO has not yet been officially announced. However, the tentative listing date is scheduled for TBA.

Bio Medica Laboratories IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at TBA.